These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16171602)

  • 21. Role of Galphaq in smooth muscle cell proliferation.
    Tanski WJ; Roztocil E; Hemady EA; Williams JA; Davies MG
    J Vasc Surg; 2004 Mar; 39(3):639-44. PubMed ID: 14981460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role and mechanism of tissue plasminogen activator in venous wall fibrosis remodeling after deep venous thrombosis via the glycogen synthase kinase-3 beta signaling pathway.
    Yin M; Tian S; Huang X; Huang Y; Jiang M
    J Surg Res; 2013 Oct; 184(2):1182-95. PubMed ID: 23632004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular smooth muscle cell growth, migration, and neointimal hyperplasia.
    Cai Y; Nagel DJ; Zhou Q; Cygnar KD; Zhao H; Li F; Pi X; Knight PA; Yan C
    Circ Res; 2015 Mar; 116(7):1120-32. PubMed ID: 25608528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased neointimal formation in cystathionine gamma-lyase deficient mice: role of hydrogen sulfide in α5β1-integrin and matrix metalloproteinase-2 expression in smooth muscle cells.
    Yang G; Li H; Tang G; Wu L; Zhao K; Cao Q; Xu C; Wang R
    J Mol Cell Cardiol; 2012 Mar; 52(3):677-88. PubMed ID: 22200376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitric oxide stimulates matrix synthesis and deposition by adult human aortic smooth muscle cells within three-dimensional cocultures.
    Simmers P; Gishto A; Vyavahare N; Kothapalli CR
    Tissue Eng Part A; 2015 Apr; 21(7-8):1455-70. PubMed ID: 25597545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial cell effect on smooth muscle cell collagen synthesis.
    Powell RJ; Hydowski J; Frank O; Bhargava J; Sumpio BE
    J Surg Res; 1997 Apr; 69(1):113-8. PubMed ID: 9202656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endograft technology: a delivery vehicle for intravascular gene therapy.
    Eton D; Yu H; Wang Y; Raines J; Striker G; Livingstone A
    J Vasc Surg; 2004 May; 39(5):1066-73. PubMed ID: 15111863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells.
    Galis ZS; Kranzhöfer R; Fenton JW; Libby P
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):483-9. PubMed ID: 9102166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of proteolytic enzymes and inhibitors in two smooth muscle cell phenotypes.
    Lau HK
    Cardiovasc Res; 1999 Sep; 43(4):1049-59. PubMed ID: 10615432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model.
    Li Y; Minamino T; Tsukamoto O; Yujiri T; Shintani Y; Okada K; Nagamachi Y; Fujita M; Hirata A; Sanada S; Asanuma H; Takashima S; Hori M; Johnson GL; Kitakaze M
    Circulation; 2005 Apr; 111(13):1672-8. PubMed ID: 15795331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM; Roztocil E; Davies MG
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin.
    Luo M; Ji Y; Luo Y; Li R; Fay WP; Wu J
    J Thromb Haemost; 2017 Dec; 15(12):2451-2460. PubMed ID: 29028290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor.
    Eefting D; de Vries MR; Grimbergen JM; Karper JC; van Bockel JH; Quax PH
    J Vasc Surg; 2010 Feb; 51(2):429-37. PubMed ID: 20036101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial cell activation of the smooth muscle cell phosphoinositide 3-kinase/Akt pathway promotes differentiation.
    Brown DJ; Rzucidlo EM; Merenick BL; Wagner RJ; Martin KA; Powell RJ
    J Vasc Surg; 2005 Mar; 41(3):509-16. PubMed ID: 15838487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seeding of vascular grafts with genetically modified endothelial cells. Secretion of recombinant TPA results in decreased seeded cell retention in vitro and in vivo.
    Dunn PF; Newman KD; Jones M; Yamada I; Shayani V; Virmani R; Dichek DA
    Circulation; 1996 Apr; 93(7):1439-46. PubMed ID: 8641034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane-type matrix metalloproteinase-1 and -3 activity in primate smooth muscle cells.
    Shofuda KI; Hasenstab D; Kenagy RD; Shofuda T; Li ZY; Lieber A; Clowes AW
    FASEB J; 2001 Sep; 15(11):2010-2. PubMed ID: 11511522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
    Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A
    Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling.
    Galis ZS; Johnson C; Godin D; Magid R; Shipley JM; Senior RM; Ivan E
    Circ Res; 2002 Nov; 91(9):852-9. PubMed ID: 12411401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation.
    Duran-Prado M; Morell M; Delgado-Maroto V; Castaño JP; Aneiros-Fernandez J; de Lecea L; Culler MD; Hernandez-Cortes P; O'Valle F; Delgado M
    Circ Res; 2013 May; 112(11):1444-55. PubMed ID: 23595952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells.
    Herbert JM; Lamarche I; Prabonnaud V; Dol F; Gauthier T
    J Biol Chem; 1994 Jan; 269(4):3076-80. PubMed ID: 8300642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.